Federal Register of Legislation - Australian Government

Primary content

PB 75 of 2019 Determinations/Health as made
This instrument amends the National Health (Weighted average disclosed price – October 2019 reduction day) Determination 2019 (PB 45 of 2019) to reduce the approved ex-manufacturer price of certain Pharmaceutical Benefits Scheme medicines that were calculated as a result of price disclosure, and to adjust the approved ex-manufacturer prices of brands amended to reflect changes that have resulted from the dispute resolution process.
Administered by: Health
Registered 21 Aug 2019
Tabling HistoryDate
Tabled HR09-Sep-2019
Tabled Senate09-Sep-2019
Date of repeal 15 Nov 2019
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003

 

PB 75 of 2019

National Health (Weighted average disclosed price – October 2019 reduction day) Amendment Determination 2019

National Health Act 1953

I, ADRIANA PLATONA, First Assistant Secretary, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 99ADB(4) of the National Health Act 1953.

Dated:   15 August 2019

 

 

 

 

 

 

 

 

 

ADRIANA PLATONA

First Assistant Secretary

Technology Assessment and Access Division

Department of Health

 

 

 


1              Name of Instrument

       (1)     This instrument is the National Health (Weighted average disclosed price – October 2019 reduction day) Amendment Determination 2019.

       (2)     This instrument may also be cited as PB 75 of 2019.

2              Commencement

                This instrument commences on the day after it is registered.

3                   Amendments to PB 45 of 2019

This instrument amends the National Health (Weighted average disclosed price – October 2019 reduction day) Determination 2019 (PB 45 of 2019).

 

 


Schedule 1     Amendments

 

[1]     Schedule 1

omit:

5

Bivalirudin

Powder for I.V. injection 250 mg (as trifluoroacetate)

Injection

Angiomax

417.93

6

Bivalirudin

Powder for I.V. injection 250 mg (as trifluoroacetate)

Injection

Bivalirudin APOTEX

417.93

 

 


[2]     Schedule 1

omit:

44

Epirubicin

Solution for injection containing epirubicin hydrochloride 100 mg in 50 mL

Injection/Intravesical

Epirubicin ACT

18.07

45

Epirubicin

Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL

Injection/Intravesical

Epirube

36.14

46

Epirubicin

Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL

Injection/Intravesical

Epirubicin Accord

36.14

47

Epirubicin

Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL

Injection/Intravesical

Epirubicin ACT

36.14

48

Epirubicin

Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL

Injection/Intravesical

Pharmorubicin

36.14

49

Epirubicin

Solution for injection containing epirubicin hydrochloride 50 mg in 25 mL

Injection/Intravesical

Epirube

9.04

50

Epirubicin

Solution for injection containing epirubicin hydrochloride 50 mg in 25 mL

Injection/Intravesical

Epirubicin ACT

9.04

51

Epirubicin

Solution for injection containing epirubicin hydrochloride 50 mg in 25 mL

Injection/Intravesical

Pharmorubicin

9.04

 

 

[3]     Schedule 1

omit:

99

Ivabradine

Tablet 5 mg (as hydrochloride)

Oral

APO-Ivabradine

27.32

100

Ivabradine

Tablet 5 mg (as hydrochloride)

Oral

Coralan

27.32

101

Ivabradine

Tablet 7.5 mg (as hydrochloride)

Oral

APO-Ivabradine

27.32

102

Ivabradine

Tablet 7.5 mg (as hydrochloride)

Oral

Coralan

27.32

 

 

[4]     Schedule 1

omit:

113

Pemetrexed

Powder for I.V. infusion 1 g (as disodium)

Injection

DBL Pemetrexed

51.92

114

Pemetrexed

Powder for I.V. infusion 1 g (as disodium)

Injection

Pemetrexed Accord

51.92

115

Pemetrexed

Powder for I.V. infusion 100 mg (as disodium)

Injection

Alimta

5.19

116

Pemetrexed

Powder for I.V. infusion 100 mg (as disodium)

Injection

DBL Pemetrexed

5.19

117

Pemetrexed

Powder for I.V. infusion 100 mg (as disodium)

Injection

Pemetrexed Accord

5.19

118

Pemetrexed

Powder for I.V. infusion 100 mg (as disodium)

Injection

PEMETREXED-DRLA

5.19

119

Pemetrexed

Powder for I.V. infusion 100 mg (as disodium)

Injection

Reladdin

5.19

120

Pemetrexed

Powder for I.V. infusion 100 mg (as disodium)

Injection

Tevatrexed

5.19

121

Pemetrexed

Powder for I.V. infusion 500 mg (as disodium)

Injection

Alimta

25.96

122

Pemetrexed

Powder for I.V. infusion 500 mg (as disodium)

Injection

DBL Pemetrexed

25.96

123

Pemetrexed

Powder for I.V. infusion 500 mg (as disodium)

Injection

Pemetrexed Accord

25.96

124

Pemetrexed

Powder for I.V. infusion 500 mg (as disodium)

Injection

Pemetrexed APOTEX

25.96

125

Pemetrexed

Powder for I.V. infusion 500 mg (as disodium)

Injection

Pemetrexed DRLA

25.96

126

Pemetrexed

Powder for I.V. infusion 500 mg (as disodium)

Injection

Reladdin

25.96

127

Pemetrexed

Powder for I.V. infusion 500 mg (as disodium)

Injection

Tevatrexed

25.96

 

 

Schedule 2     Amendments

 

[5]     Schedule 2

after:

485

Bisoprolol

Tablet containing bisoprolol fumarate 5 mg

Oral

Terry White Chemists Bisoprolol

6.49


insert:

485A

Bivalirudin

Powder for I.V. injection 250 mg (as trifluoroacetate)

Injection

Angiomax

474.81

485B

Bivalirudin

Powder for I.V. injection 250 mg (as trifluoroacetate)

Injection

Bivalirudin APOTEX

474.81

 

 

[6]     Schedule 2

after:

1766

Isosorbide mononitrate

Tablet 60 mg (sustained release)

Oral

Terry White Chemists Isosorbide Mononitrate

3.29

 

insert:

1766A

Isotretinoin

Capsule 5 mg

Oral

Oratane

11.01

 

 

[7]     Schedule 2

after:

1785

Itraconazole

Capsule 50 mg

Oral

Lozanoc

101.95

 

insert:

1785A

Ivabradine

Tablet 5 mg (as hydrochloride)

Oral

APO-Ivabradine

31.03

1785B

Ivabradine

Tablet 5 mg (as hydrochloride)

Oral

Coralan

31.03

1785C

Ivabradine

Tablet 7.5 mg (as hydrochloride)

Oral

APO-Ivabradine

31.03

1785D

Ivabradine

Tablet 7.5 mg (as hydrochloride)

Oral

Coralan

31.03